A股異動 | 寶鼎科技七連板 成交額放大至逾8億元
寶鼎科技(002552.SZ)放量漲停,報16.86元,成交額放大至逾8億元,最新總市值51億,換手率24.8%。公司昨日發佈股票交易異常波動公告稱,公司前期披露的信息不存在需要更正或補充披露的事項;公司生產經營正常,主營業務穩定,內、外部經營環境未發生重大變化。公司此前發佈公告稱,控股股東及相關股東擬將持有的9156.35萬股公司股份以10.06元/股轉讓予招金集團。完成後,招金集團通過轉讓所得及要約收購將直接持有公司不少於1.1606億股公司股份,佔公司總股本的37.9%,招金集團將成為公司控股股東,山東省招遠市人民政府將成為公司的實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.